Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C H Functionalization. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced synthesis of loteprednol etabonate intermediate via 11-alpha-hydroxy-ADD. High purity, cost-effective route for ophthalmic steroid manufacturing.
Novel iodine-catalyzed selenization method for imidazopyridine derivatives ensures high purity and scalable production for global pharmaceutical supply chains.
Patent CN103788164A reveals a scalable route for fulvestrant using stable isothiourea reagents, offering significant cost reduction and high-purity API intermediate manufacturing capabilities.
Patent CN110746349A reveals a novel Ru-catalyzed meta-selective C-H functionalization route for high-purity phenoxypyridine derivatives, offering significant supply chain advantages.
Patent CN109503600A reveals a primary amine-directed synthesis route offering high yield and mild conditions for cost reduction in pharmaceutical intermediates manufacturing.
Efficient synthesis of planar chiral ferrocenes using chiral amino acids. Reliable supplier for high-purity pharmaceutical intermediates with reduced manufacturing costs.
Advanced synthesis of 16β-methyl steroid intermediates via novel dehydration and epoxidation. Cost-effective route for Betamethasone precursors ensuring high purity.
Patent CN101735042B details a palladium-catalyzed route for high-purity pharmaceutical intermediates, offering streamlined manufacturing and cost reduction.
Patent CN112010918A details a novel cyanation route for 17-beta-hydroxy steroids, eliminating toxic mercury catalysts and enabling high-purity impurity reference standards for pharmaceutical quality control.
Patent CN103553857A reveals a photocatalytic method for direct ortho-trifluoromethylation. Discover cost reduction in fine chemical manufacturing and scalable supply solutions.
Novel palladium-catalyzed route offers high yield and mild conditions for pharmaceutical intermediates, ensuring cost reduction and supply chain reliability.
Discover a novel Pd-catalyzed synthesis for seven-membered indoloazepine CYP1B1 inhibitors. Efficient route, broad substrate scope, and scalable manufacturing for pharmaceutical applications.
Patent CN118164894A reveals a mild silver-catalyzed route for 3-aminoindoles, offering cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN114835615A details a metal-free radical thiolation method for synthesizing organosulfur compounds, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Discover the novel synthesis of 3-hydroxy-cepham compounds via CN101525341B. Achieve high purity and cost reduction in antibiotic manufacturing with our scalable routes.
Patent CN111960997B reveals a mild silver-catalyzed route for hydroxyalkyl quinolines, offering cost reduction and high purity for pharmaceutical intermediate manufacturing.
Patent CN112979645B reveals a novel Lewis acid-catalyzed route for indolizine derivatives, offering significant cost reduction and green chemistry benefits for API manufacturing.
Patent CN111440109A details a novel copper-catalyzed route using Bunte salts for high-purity maleimide intermediates, offering significant cost and supply chain advantages.
Novel green chemistry route for alpha-acyloxy thioethers using Selectfluor. Reduces toxicity and cost for pharmaceutical intermediates manufacturing.
Patent CN102503747B reveals a novel Pd-catalyzed synthesis for polyfluoroaromatic-heteroaromatic blocks, offering cost reduction and high purity for optoelectronic manufacturing.